Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership
All
13F
13D/G
Other
Tags
CC transcript
|
|
GSK plc (GSK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/16/2023 |
SC 13D/A
| GSK plc reports a 10.9% stake in Haleon plc |
| 01/20/2023 |
SC 13D/A
| GSK PLC reports a 12.2% stake in 23ANDME HOLDING CO. |
| 01/20/2023 |
SC 13D/A
| GSK PLC reports a 17.8% stake in SPERO THERAPEUTICS, INC. |
| 11/14/2022 |
SC 13D/A
| GSK PLC reports a 20% stake in SPERO THERAPEUTICS, INC. |
| 09/20/2022 |
SC 13D/A
| GSK PLC reports a 0% stake in THERAVANCE BIOPHARMA, INC. |
| 08/03/2022 |
SC 13D/A
| GSK PLC reports a 12.7% stake in THERAVANCE BIOPHARMA, INC. |
| 05/13/2022 |
SC 13D/A
| GSK PLC reports a 6.8% stake in Nkarta, Inc. |
| 02/10/2022 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 13.1% stake in THERAVANCE BIOPHARMA, INC. |
| 09/16/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 5.4% stake in SPERO THERAPEUTICS, INC. |
| 09/16/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 6% stake in BICYCLE THERAPEUTICS PLC |
| 05/25/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 0% stake in INNOVIVA, INC. |
| 04/16/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC has filed a Schedule 13D for BICYCLE THERAPEUTICS PLC |
| 04/08/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 0% stake in Pandion Therapeutics, Inc. |
| 02/12/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 31.6% stake in INNOVIVA, INC. |
| 12/07/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 6.4% stake in SPERO THERAPEUTICS, INC. |
| 12/07/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 8.9% stake in BICYCLE THERAPEUTICS PLC |
| 11/06/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 4.9% stake in TURNING POINT THERAPETUICS, INC. |
| 09/30/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 0% stake in PRINCIPIA BIOPHARMA INC. |
| 07/10/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/22/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/17/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 15.3% stake in THERAVANCE BIOPHARMA, INC. |
| 06/04/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 8.8% stake in SPERO THERAPEUTICS, INC. |
| 05/26/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 5.5% stake in TURNING POINT THERAPETUICS, INC. |
| 02/27/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 15.5% stake in THERAVANCE BIOPHARMA, INC. |
| 02/18/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/18/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 5% stake in MORPHIC HOLDING, INC. |
| 02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 1.1% stake in TRANSLATE BIO, INC. |
| 02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 10.1% stake in SPERO THERAPEUTICS, INC. |
| 02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 9.3% stake in PRINCIPIA BIOPHARMA INC. |
| 02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 10.7% stake in BICYCLE THERAPEUTICS PLC |
| 02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 1.8% stake in AILERON THERAPEUTICS, INC. |
|
|
|